🚀 Zaprep: Your Socials on Steroids. 免费开始 ,每月 1,000 条自动私信。

AI NewsEnveda secures $311M to bring more nature-derived AI drugs into clinical trials

Enveda secures $311M to bring more nature-derived AI drugs into clinical trials

2:37 AM IST · September 24, 2026

Enveda secures $311M to bring more nature-derived AI drugs into clinical trials

Enveda, a biotech startup that uses AI to discover new drugs in the natural world, has raised a $311 million Series E at a $2 billion valuation. The fresh funding, which was led by Catalio Capital Management, with participation from Iconiq and others, doubles the valuation Enveda achieved 12 months ago. The idea behind Enveda is that powerful medicines could be harnessed from plants and microbes, rather than synthesized from scratch in a lab. Viswa Colluru, an early employee of Recursion Pharmaceuticals, founded Enveda in 2019 to speed up the process of discovering these new drugs using AI and other techniques. While AI hasn’t yet produced any FDA-approved drugs, Enveda is among the wave of companies advancing AI-discovered candidates into human clinical trials. The startup is currently testing several drugs in patients, including one targeting severe skin conditions and another designed to help maintain weight loss after stopping GLP-1s.

read more

最新 AI 资讯

查看全部资讯 →

提交您的工具

Submit AI Tools – The ultimate platform to discover, submit, and explore the best AI tools across various categories.Listed on codetrendy.comFeatured on ListBulb

PoweredByAI.app 是一个 AI 工具目录,帮助个人、企业和创作者发现写作、编程、设计、生产力等领域的最佳 AI 工具。

© 2026 , 产品来自011BQ. 保留所有权利。